Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyrotinib Plus Vinorelbine in Metastatic HER2-positive Breast Cancer Patients- a Multicenter Retrospective Study

NCT04517305 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04517305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04517305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyrotinib Plus Vinorelbine in Metastatic HER2-positive Breast Cancer Patients- a Multicenter Retrospective Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
May 15, 2018
Completion date
May 15, 2021
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer